Correction of Defective Expression in MHC Class II Deficiency (Bare Lymphocyte Syndrome) Cells by Retroviral Transduction of CIITA

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1086-1095

  Bradley, M Brigid ^a   Fernandez, Jose M ^a   Ungers, Grace ^a   Diaz Barrientos, Teresa ^a   Steimle, Viktor ^b   Mach, Bernard ^b   O'Reilly, Richard ^a   Lee, Janet S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; GAG PROTEIN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; COMBINED IMMUNODEFICIENCY; GENE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; INVARIANT CHAIN; RETROVIRUS;

ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; GENE PRODUCTS, GAG; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, MHC CLASS II; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; NUCLEAR PROTEINS; ORGAN SPECIFICITY; RETROVIRIDAE; SEVERE COMBINED IMMUNODEFICIENCY; TRANS-ACTIVATORS;

EID: 0031202294     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Griscelli, C., B. Lisowska-Grospierre, and B. Mach. 1993. Combined immunodeficiency with defective expression in MHC class II genes. In Immunodeficiencies. F. S. Rosen, and M. Seligman, eds. Harwood Academic Publishers, Chur, Switzerland, pp. 141-154.
2. Mach, B. 1995. MHC class II regulation: lessons from a disease. N. Engl. J. Med. 332:120.
3. Lisowska-Grospierre, B., D. J. Charron, C. de Preval, A. Durandy, C. Griscelli, and B. Mach. 1985. A detect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J. Clin. Invest. 76:381.
4. Hardy, D. A., J. I. Bell, E. O. Long, T. Lindsten, and H. O. McDevitt. 1986. Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis. Nature 323:453.
5. Radka, S. F., D. J. Charron, and F. M. Brodsky. 1986. Class II molecules of the major histocompatibility complex considered as differentiation markers. Hum. Immunol. 16:390.
6. Houghton, A. N., T. M. Thomson, D. Gross, H. F. Oettgen, and L. J. Old. 1984. Surface antigens of melanoma and melanocytes: specificity of induction of Ia antigens by human gamma-interferon. J. Exp. Med. 160:255.
7. Noelle, R., P. H. Krammer, J. Ohara, J. W. Uhr, and E. S. Vitetta. 1984. Increased expression of Ia antigens on resting B cells: an additional role for B cell growth factor. Proc. Natl. Acad. Sci. USA 81:6149.
8. Roehm, N. W., H. J. Leibson, A. Zlotnick, J. Kappler, P. Marrack, and J. Cambier. 1984. Interleukin-induced increase in Ia expression by normal mouse B cells. J. Exp. Med. 160:679.
9. Gladstone, P., and D. Pious. 1978. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature 271:459 (Abstr.).
10. Accolla, R. S. 1983. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1053.
11. Calman, A. F., and B. M. Peterlin. 1987. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol. 139:2489.
12. Touraine, J.-L., H. Betuel, and F. Touraine. 1984. The bare lymphocyte syndrome. In Progress in Immunodeficiency Research and Therapy I. C. Griscelli and J. Vossen, eds. Elsevier Science Publishers B.V., Amsterdam, pp. 27-34.
13. Touraine, J.-L., G.-L. Marseglia, and H. Betuel. 1985. Thirty international cases of bare lymphocyte syndrome: biological significance of HLA antigens. Exp. Hematol. 13:86.
14. Gelfand, E. W., and H.-M. Dosch. 1983. Diagnosis and classification of severe combined immunodeficiency disease. Birth Defects 19:65.
15. Zegers, B. J. M., C. J. Heijnen, J. J. Roord, W. Kuis, R. K. B. Schuurman, J. W. Sloop, and R. E. Ballieux. 1983. Defective expression of mononuclear cell membrane HLA antigens associated with combined immunodeficiency: impaired cellular interactions. Birth Defects 19:93.
16. Rijkers, G. T., J. J. Roord, F. Koning, W. Kuis, and B. J. M. Zegers. 1987. Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibilily complex (MHC) class II antigens on mononuclear cells. J. Clin. Immunol. 7:98.
17. de Preval, C., M. R. Hadam, and B. Mach. 1988. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. N. Engl. J. Med. 318:1295.
18. Plaeger-Marshal, S., A. Haas, L. T. Clement, J. V. Giogi, I. S. Y. Chen, S. G. Quan, R. A. Gatti, and E. R. Stiehm. 1988. Interferon-induced expression of class II major histocompatibility antigens in the MHC class II deficiency syndrome. J. Clin. Immunol. 8:285.
19. Hume, C. R., L. A. Shookster, N. Collins, R. O'Reilly, and J. S. Lee. 1989. Bare lymphocyte syndrome: altered class II expression in two B cell lines. Hum. Immunol. 25:1.
20. de Preval, C., B. Lisowska-Grospierre, M. Loche, C. Griscelli, and B. Mach. 1985. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291.
21. Hume, C. R., and J. S. Lee. 1989. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum. Immunol. 26:288.
22. Yang, Z., R. S. Accolla, D. Pious, B. J. M. Zegers, and J. L. Strominger. 1988. Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines. EMBO J. 7:1965.
23. Benichou, B., and J. L. Strominger. 1991. Class II antigen negative patient and mutant B cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285.
24. Seidl, H. C., C. Saraiya, Z. Osterweil, Y. P. Fu, and J. S. Lee. 1992. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J. Immunol. 148:1576.
25. Peynenburg, A., B. Godthelp, A. Van Boxel-Dezaire, and P. J. Van den Elsen. 1995. Definition of a novel complementation group in MHC class II deficiency. Immunogenetics 41:287.
26. Steimle, V., L. A. Otten, M. Zuffery, and B. Mach. 1993. Complementation cloning of an MHC class II trans-activator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
27. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA. one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
28. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II trans-activator (CIITA). Immunity 2:533.
29. Klein, C., M. Cavazzana-Calvo, F. Le Deist, N. Jabado, M. Benkerrou, S. Blanche, B. Lisowska-Grospierre, C. Griscelli, and A. Fischer. 1995. Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients. Blood 85:580.
30. Desgranges, C., M. F. Lavoue, J. Patet, and G. de-The. 1979. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains. Biomedicine 30:102.
31. Wilson, J. M., O. Danos, M. Grossman, D. H. Raulet, and R. C. Mulligan. 1990. Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hemopoietic stem cells. Proc. Natl. Acad. Sci. USA 87:439.
32. Maniatis, T., E.F. Fritsch, and J. Sambrook, eds. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
33. Lee, J. S., J. Trowsdale, P. J. Travers, J. Carey, F. Grosveld, J. Jenkins, and W. F. Bodmer. 1982. Sequence of an HLA-DR alpha-chain cDNA clone and intronexon organization of the corresponding gene. Nature 299:750.
34. Sartoris, S., E. B. Cohen, and J. S. Lee. 1987. A rapid and improved method for generating cDNA libraries in plasmid and phage lambda vectors. Gene 56:301.
35. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
36. Cleveland, D. W., M. A. Lopata, R. J. MacDonald, N. J. Cowan, W. J. Rutter, and M. W. Kirschner. 1980. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95.
37. Kernan, N. A. N. H. Collins, L. Juliano, T. Cartagena, B. Dupont, and R. J. O'Reilly. 1986. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-vs-host disease. Blood 68:770
38. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1995. Regulation of MHC class II expression by interferon-gamma mediated by the trans-activator gene CIITA. Science 265:107.
39. Emerman, M., and H. M. Temin. 1984 Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459.
40. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400.
41. Miller, A. D., J. V. Garcian, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220.
42. Varmus, H. E. 1982. Form and function of retroviral proviruses. Science 216::812 (Review).
43. Chang, C. H., and R. A. Flavell. 1995. Class II trans-activator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
44. Scherdin, U., K. Rhodes, and M. Breindl. 1990. Transcriptionally active genome regions are preferred targets for retrovirus integration. J. Virol. 64:907.
45. Mosier, D. E. 1990. Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases. J. Clin. Immunol. 10:185.
46. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II trans-activator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
47. Challita, P. M., and D. B. Kohn. 1994. Lack of expression from a retroviral vector after transduction of murine hemopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91:2567.
48. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.